MedPath

Technische Universität Dresden

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Individualized Radiation Dose Prescription in HNSCC Based on F-MISO-PET Hypoxia-Imaging

Phase 2
Not yet recruiting
Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
Radiation: dose-escalated radiochemotherapy
Radiation: standard radiochemotherapy
Radiation: dose-escalated radiochemotherapy with carbon ion boost
First Posted Date
2019-03-06
Last Posted Date
2023-09-11
Lead Sponsor
Technische Universität Dresden
Target Recruit Count
276
Registration Number
NCT03865277
Locations
🇩🇪

Uniklinikum Wuerzburg, Würzburg, Bavaria, Germany

🇩🇪

Mechthild Krause, Dresden, Saxony, Germany

🇩🇪

Universitätsklinikum Leipzig, Leipzig, Saxony, Germany

and more 5 locations

MRD-guided Treatment in NPM1mut AML Patients

Phase 2
Recruiting
Conditions
Acute Myeloid Leukemia
Interventions
First Posted Date
2018-12-07
Last Posted Date
2024-11-06
Lead Sponsor
Technische Universität Dresden
Target Recruit Count
28
Registration Number
NCT03769532
Locations
🇩🇪

Klinikum Chemnitz, Chemnitz, Germany

🇩🇪

Universitätsklinikum Dresden, Dresden, Germany

🇩🇪

Universitätsklinikum Heidelberg, Heidelberg, Germany

and more 7 locations

Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen

Phase 3
Active, not recruiting
Conditions
Renal Failure
Renal Insufficiency
Renal Insufficiency, Chronic
Renal Disease
Interventions
First Posted Date
2018-09-14
Last Posted Date
2022-08-03
Lead Sponsor
Technische Universität Dresden
Target Recruit Count
400
Registration Number
NCT03672110
Locations
🇩🇪

Universitätsklinikum Carl Gustav Carus, Dresden, Germany

Outcomes 8 Years After Minimal Invasive THA

Not Applicable
Completed
Conditions
Osteoarthritis, Hip
Interventions
Other: surgical approach
First Posted Date
2018-09-05
Last Posted Date
2018-09-05
Lead Sponsor
Technische Universität Dresden
Target Recruit Count
157
Registration Number
NCT03657953
Locations
🇩🇪

University Hospital Dresden, Orthopaedic Department, Dresden, Germany

Investigation of the Efficacy of Acamprosate and Calcium in Comparison to Placebo as Validation of a Behavioural Test for Alcohol Dependence

Phase 3
Completed
Conditions
Alcoholism
Interventions
Drug: Placebo
Drug: Placebo lead in
First Posted Date
2018-08-17
Last Posted Date
2024-05-29
Lead Sponsor
Technische Universität Dresden
Target Recruit Count
82
Registration Number
NCT03634917
Locations
🇩🇪

Klinik und Poliklinik für Psychiatrie und Psychotherapie; Technische Universität Dresden, Dresden, Sachsen, Germany

Evaluation of the Effect of Rehabilitation Sport After Total Hip Arthroplasty (THA)

Not Applicable
Completed
Conditions
Osteoarthritis, Hip
Total Hip Arthroplasty
Sports Physical Therapy
Interventions
Behavioral: rehabilitation sport
First Posted Date
2018-07-12
Last Posted Date
2018-08-17
Lead Sponsor
Technische Universität Dresden
Target Recruit Count
160
Registration Number
NCT03584451

Psychotropic Medication and Psychotherapeutic Treatment of Adults With Intellectual Disabilities

Completed
Conditions
Intellectual Disability
First Posted Date
2018-06-15
Last Posted Date
2019-07-22
Lead Sponsor
Technische Universität Dresden
Target Recruit Count
197
Registration Number
NCT03558815
Locations
🇩🇪

Department of psychiatry and Psychotherapy, Dresden, Germany

Burden and Medical Care of Sarcoma in Germany

Completed
Conditions
Sarcoma
First Posted Date
2018-05-11
Last Posted Date
2021-08-27
Lead Sponsor
Technische Universität Dresden
Target Recruit Count
1309
Registration Number
NCT03521531
Locations
🇩🇪

University Hospital Dresden, Dresden, Saxony, Germany

Addiction in Adolescence - Pathomechanisms and Treatment Evaluation

Not Applicable
Conditions
Substance Use Disorders
Adolescent Behavior
Interventions
Other: adapted treatment according to the MATRIX-A therapy
First Posted Date
2018-02-26
Last Posted Date
2019-04-01
Lead Sponsor
Technische Universität Dresden
Target Recruit Count
450
Registration Number
NCT03444974
Locations
🇩🇪

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital C.G.Carus, Dresden, Saxony, Germany

Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases

Phase 2
Terminated
Conditions
Malignant Melanoma Stage IV
BRAF V600 Mutation
Brain Metastases
Interventions
First Posted Date
2018-02-13
Last Posted Date
2023-09-14
Lead Sponsor
Technische Universität Dresden
Target Recruit Count
20
Registration Number
NCT03430947
Locations
🇩🇪

Technische Universität Dresden, Dresden, Germany

🇩🇪

Ruprecht-Karls-University of Heidelberg, Faculty of Medicine, Heidelberg, Germany

🇩🇪

Eberhard Karls University of Tübingen, University Medical Center, Tuebingen, Germany

© Copyright 2025. All Rights Reserved by MedPath